Title | Creator | Relation Is Part Of | ||
---|---|---|---|---|
1 | Neuro-Ophthalmic Consequences of Medications for Multiple Sclerosis: The Good, The Bad, The Ugly and The Unknown (abstract) | Heather E. Moss, MD, PhD | NANOS 2017: Neuro-Ophthalmologic Side Effects of More Recently Used Medications in Treating Cancer, Rheumatologic Disorders, and Multiple Sclerosis | |
2 | Neuro-Ophthalmic Consequences of Medications for Multiple Sclerosis: The Good, The Bad, The Ugly and The Unknown (video) | Heather E. Moss, MD, PhD | NANOS Annual Meeting 2017: Neuro-Ophthalmologic Side Effects of More Recently Used Medications in Treating Cancer, Rheumatologic Disorders, and Multiple Sclerosis | |
3 | Infectious Risks With Immunosuppressive Therapy Used to Treat Common Neuro-Ophthalmic Disorders | Lindsey B. De Lott | NANOS Annual Meeting 2021: Infectious Diseases in Neuro-Ophthalmology: It's Not Just COVID-19 | |
4 | Infectious Risks With Immunosuppressive Therapy Used to Treat Common Neuro-Ophthalmic Disorders | Lindsey B. De Lott | NANOS Annual Meeting 2021: Infectious Diseases in Neuro-Ophthalmology: It's Not Just COVID-19 |